<qa>  What is the effect of dapagliflozin 10 mg on heart failure disease-A 12-week randomized, double-blind, placebo-controlled trial to evaluate the effects of once-daily dapagliflozin 10 mg on heart failure disease-specific biomarkers BNP and NTproBNP, symptoms, health status, and quality of life in patients with type 2 diabetes and chronic heart failure with reduced systolic function. 